Researchers Alex Bazhaniuk and Mickey Shkatov said the iSeq 100 was running in Compatibility Support Mode, which allows the ...

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines. The ...

Researchers from Eclypsium find vulnerability in the way iSeq 100 boots up The bug allows threat actors to establish persistence, brick the device, or tamper with the results A patch has since been ...

Eclypsium security researchers have uncovered UEFI vulnerabilities in the Illumina iSeq 100 DNA sequencer, but the broader issue involves the device development process at large.

What's it like to build the software in a brand-new sequencer? Illumina's Aneesh Natarajan takes us on the journey Originally ...

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.

Certain vulnerabilities in device maker Illumina's iSeq 100 DNA gene sequencer could allow hackers to overwrite the system's ...

On Tuesday, researchers from firmware security firm Eclypsium called out one of them: the Illumina iSeq 100, a DNA sequencer that's a staple at 23andMe and thousands of other gene-sequencing ...

Currently, Illumina has a market capitalization of $22.18 billion. Buying $100 In ILMN: If an investor had bought $100 of ILMN stock 20 years ago, it would be worth $3,290.99 today based on a ...

The Illumina MiSeq i100 Series, announced last fall, is the company's first customer-installable instrument since the iSeq. Illumina's latest offering was a brand-new challenge for Staff Software ...